We follow the science toward therapies with untapped potential and amplify their ability to address unmet needs. We leverage our proven expertise to advance our portfolio of one-and-only …

TerSera Therapeutics is a biopharmaceutical company with a focus in oncology, acute care, and non-opioid pain management. Since 2016, we have come together to build a patient- and …

Jul 18, 2025 · PRIALT is a non-opioid intrathecal analgesic indicated for the management of severe chronic pain in patients for whom intrathecal therapy is warranted and who are …

Information on valuation, funding, acquisitions, investors, and executives for Tersera Therapeutics. Use the PitchBook Platform to explore the full profile.

TerSera Canada builds partnerships in urology and oncology, ensuring treatment is delivered to patients when and where they need it. We leverage our experience, along with an active and …

Jul 18, 2025 · TerSera Therapeutics is a biopharmaceutical company with a focus in oncology, rare disease, and non-opioid pain management. Founded in 2016, TerSera is building new …

Oct 22, 2024 · Founded in 2016, TerSera is building new cornerstones of care through its portfolio of unique therapeutics, amplifying their ability to deliver meaningful outcomes for patients.

Nov 1, 2024 · TerSera Therapeutics, focused on oncology and non-opioid pain management, was founded in 2016. The company is committed to delivering meaningful outcomes for patients …

Our team has a proven track record in drug development, commercialization, patient support, and business development, delivering a unique portfolio of one-and-only therapeutics across a …

Committed to providing the resources and support patients and providers need to navigate treatment. TerSera’s products make a difference for patients and provide solutions for providers.